A logistic model with four out of the six salivary biomarkers (KRAS, SAT1, EGRF, and PSMB2) discriminated T2D patients from healthy controls (AUC: 0.917, 95% CI: 0.809–1.000). This evidence concerns the gene KRAS and type 2 diabetes mellitus.